“`html


    At this moment, Ito Yuihiko remarked once more: “I have always held a positive outlook on Kobayashi Pharmaceuticals and am eager to support its future growth. That’s why I’m here today—to finalize an investment agreement with you. I trust you’re on board with my investment intentions?”


    Kobayashi Masayoshi quickly responded with respect: “Chairman Ito, rest assured, we reached a consensus prior to your arrival, and we warmly wee your investment in Kobayashi Pharmaceuticals.”


    Yuihiko Ito nodded, wanting to avoid any unnecessary dys. He stated directly: “Well, I have manymitmentstely and will be leaving Tokyo tomorrow, so let’s sign the contract now. If everything looks good, I’ll alert the finance team to proceed with the transfer.”


    Kobayashi Masayoshi eagerly said: “No problem! Absolutely no issues—we can sign the contract immediately!”<fn13aa> ???s ??????? ?s ?????? ?? find~novel</fn13aa><h3 style="background-color:DodgerBlue">


    Ito Yuihiko then turned to Koichi Tanaka, who was beside him: “Tanaka, please bring out the contract for everyone to review.”


    Koichi Tanaka quickly produced several copies of the contract and distributed them, exining: “Everyone, the details of the investment are outlined in the contract. We have valued Kobayashi Pharmaceuticals at $15 billion for this investment, and we intend to invest $100 million, acquiring 30% of the shares. If there are no objections, we can sign the contract now and arrange for the financial transfer immediately after.”


    As everyone examined the contract, they found no hidden terms or risks. They all turned to Kobayashi Masayoshi, urging him to sign the agreement.


    Eager to conclude the matter, Kobayashi Masayoshi swiftly signed the contract as the acting chairman.


    Once the contract was finalized, Ito Yuihiko promptly notified the finance team, resulting in a $4.5 billion credit to Kobayashi Pharmaceuticals’ ount.


    The remaining step was for the board members of Kobayashi Pharmaceuticals to submit an application to Tokyo’smercial management department to officially transfer 30% of thepany’s shares to the Ito family.


    Upon hearing that the $4.5 billion had been credited, Kobayashi Masayoshi was filled with excitement. He shook hands with Ito Yuihiko and eximed, “Mr. Ito, you are now a shareholder of Kobayashi Pharmaceuticals!”


    Yuihiko Ito chuckled and responded, “Don’t worry, I won’t interfere with your operational decisions. Just focus on excelling and striving to make Kobayashi Pharmaceuticals the leading pharmaceuticalpany in the world, and we’ll all benefit!”


    Kobayashi Masayoshi then addressed the surrounding executives: “Come on, everyone, let’s give a round of apuse to wee Mr. Ito as a shareholder of Kobayashi Pharmaceuticals!”


    The room filled with smiles and apuse.


    Suddenly, the conference room door swung open. Charlie entered with a serious expression and asked coldly, “What’s all thismotion?”


    Everyone turned to Charlie, momentarily stunned. Who was this person? Why had they never seen him before? What was he doing here?


    Ito Yuihiko, taken aback by the unexpected interruption, retorted, “Who are you? How dare you enter this space?”


    Charlie met his gaze and replied coolly, “Old man, I’m a major shareholder of Kobayashi Pharmaceuticals. Do you really think I can’te in?”


    “What a joke!” Kobayashi Zhengyi shot back. “You aren’t even part of Kobayashi Pharmaceuticals, so how can you im to be a major shareholder?”


    At that moment, Tanaka recognized Charlie and eximed, “Mr. Wade, what are you doing here?”


    Seeing Tanaka, Charlie snorted and said, “Tanaka, it seems you’re everywhere I go!”


    Ito Yuihiko turned to Tanaka, inquiring urgently, “Tanaka, do you know him?!”


    Koichi Tanaka quickly approached Ito Yuihiko and whispered, “Mr. Ito, this is Charlie Wade—the one who dealt with Mr. Yamamoto Kazuki…”


    “`